What is CorMedix's conversion of stock amount issued1?

CorMedix (CRMD) reported conversion of stock amount issued1 of $12.32M in Q4 2025.

What does conversion of stock amount issued1 mean?

Quantifies the value of equity issued as a result of the conversion of convertible securities, such as convertible debt or preferred stock, into common shares. This metric tracks the dilution impact and the shift in capital structure from debt or hybrid instruments to common equity.

CorMedix CRMD Conversion Of Stock Amount Issued1

Conversion Of Stock Amount Issued1 at other companies

CorMedixCRMD

$12.32M—

Ondas, Inc. ONDS

$46.37K+101%

Silvaco Group, Inc.SVCO

$0-100%

ZymeworksZYME

$0—

HarmonicHLIT

0-100%

Red Rock Resorts, Inc.RRR

100K—

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountIssued1.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's conversion of stock amount issued1.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's conversion of stock amount issued1?: CorMedix (CRMD) reported conversion of stock amount issued1 of $12.32M in Q4 2025.
What does conversion of stock amount issued1 mean?: Quantifies the value of equity issued as a result of the conversion of convertible securities, such as convertible debt or preferred stock, into common shares. This metric tracks the dilution impact and the shift in capital structure from debt or hybrid instruments to common equity.